Trial Profile
A Retrospective study to evaluate the survival outcomes of Clopidogrel, Prasugrel and Ticagrelor in patients with Acute Coronary Syndromes treated with Percutaneous Coronary Intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 18 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology